We subsequently conducted immunohistochemical analyses on formalin-fixed tumor slices and recorded an increased presence of CD45+/ CD68+ cells having an elevated expression of Arg-1 and TGF-β1 in tumors from gemcitabine-treated mice, compared to those treated with vehicle only (Fig. 1C). Here, ARG1 is linked to neoplasm.